Fifth, biopsy skin tissues from individuals with AD and PSP showed significantly higher levels of tau-SA compared to normal controls, implying the potential of sTau-SA as a diagnostic biomarker for living tauopathy patients. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.